BridgeMD
Compares treatment options for Lumbar Disc Herniation
Official title Non-pharmacological Treatment vs Pharmacological Treatment for Non-acute Lumbar Disc Herniation
ClinicalTrials.gov ID: NCT06024460
What this study is testing
- What it's testing
- This is a randomized controlled study comparing non-pharmacological treatment to proactive pharmacological treatment for patient with non-acute lumbar disc herniation with moderate or higher levels of pain. The study involves 200 adult patients aged 19-69, with 50 patients from each participating hospital.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 69
You may be able to join if
- aged 19 to 69 years.
- lower back pain that has persisted for at least 1 month.
- a Numeric Rating Scale (NRS) score of 5 or higher for either lower back pain or radiating leg pain over the past three consecutive days.
- confirmed lumbar disc herniation on MRI that can explain the lower back pain.
- who have provided written informed consent and agreed to participate in the clinical study.
You likely can't join if
- diagnosed with specific severe diseases that could be the cause of lower back pain or leg pain (e.g., spinal metastasis, acute fractures, and spinal...
- showing progressive neurological deficits or severe neurological symptoms.
- with pain originating from soft tissue disorders other than the spine (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout).
- with other chronic conditions (e.g., stroke and myocardial infarction, renal disease, diabetic neuropathy, dementia, epilepsy) that may interfere...
- taking steroids, immunosuppressive drugs, psychiatric medications, or other medications that may impact the study results.
- acupuncture or nerve block treatment is inappropriate or unsafe, such as those with a history of bleeding disorders, receiving anticoagulant therapy...
See the full eligibility criteria
- aged 19 to 69 years.
- lower back pain that has persisted for at least 1 month.
- a Numeric Rating Scale (NRS) score of 5 or higher for either lower back pain or radiating leg pain over the past three consecutive days.
- confirmed lumbar disc herniation on MRI that can explain the lower back pain.
- who have provided written informed consent and agreed to participate in the clinical study.
- diagnosed with specific severe diseases that could be the cause of lower back pain or leg pain (e.g., spinal metastasis, acute fractures, and spinal dislocation).
- showing progressive neurological deficits or severe neurological symptoms.
- with pain originating from soft tissue disorders other than the spine (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout).
- with other chronic conditions (e.g., stroke and myocardial infarction, renal disease, diabetic neuropathy, dementia, epilepsy) that may interfere with the treatment effect or result interpretation.
- taking steroids, immunosuppressive drugs, psychiatric medications, or other medications that may impact the study results.
- acupuncture or nerve block treatment is inappropriate or unsafe, such as those with a history of bleeding disorders, receiving anticoagulant therapy, or diagnosed with uncontrolled diabetes.
- taken non-steroidal anti-inflammatory drugs (NSAIDs) or other pain-affecting drugs or received acupuncture treatment within the past 5 days.
- Pregnant women, those planning pregnancy, or breastfeeding women.
- within 3 months after lumbar surgery.
- who have not completed participation in another clinical study within the past month or have plans to participate in another clinical study within 6 months from the selection date or during the study participation and...
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Gangnam-Gu, South Korea
- Bucheon-si, Gyeonggi-do, South Korea
- Busan, South Korea
- Daejeon, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 69 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Gangnam-Gu, South Korea; Bucheon-si, Gyeonggi-do, South Korea; Busan, South Korea; Daejeon, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.